Dana Farber Cancer institution

Boston, Massachusetts 02215

1 studies enrolling now · 3 studies all time

What they study most

Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors, Breast Cancer, Cholangiocarcinoma, Gastric Cancer, Melanoma, Mismatch Repair-Proficient Colorectal Cancer, Non-Small Cell Lung Cancer, Primary CNS Tumors, Relapsed or Refractory Multiple Myeloma, Urothelial Cancer

Studies at this site

• Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of TAS-120 in Patients With Advanced Solid Tumors — Completed
• Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) — Completed